Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹-828 Cr₹-265 Cr₹625 Cr₹1,109 Cr₹1,131 Cr

What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS is ₹-828 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹-828 Cr
Mar2024₹-265 Cr
Mar2023₹625 Cr
Mar2022₹1,109 Cr
Mar2021₹1,131 Cr

How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹-828 Cr
Negative
Mar2024 ₹-265 Cr
Negative
Mar2023 ₹625 Cr
-43.59
Mar2022 ₹1,109 Cr
-1.99
Mar2021 ₹1,131 Cr -

Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,893.5 Cr -2% 0.6% -1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2%

0.6%

-1%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses